Brief Description
Vedere Bio, Inc. was developing gene therapy products to restore functional vision to patients who have suffered vision loss from inherited retinal degenerations, as well as other causes of both genetic and non-genetic vision loss. Vedere aimed to restore lost vision regardless of a patient's underlying genetics or their stage of disease.
Vedere was acquired by Novartis in 2020.
Timeline
- 2019. Company founded
- 2020. Vedere acquired by Novartis
Inventors
Ehud Isaacoff, John Flannery, Amy Holt, Autoosa Salari, Benjamin Gaub, Dirk Trauner, Doris Fortin, Johannes Broichhagen, Joshua Levitz, Karen Isabelle Guerin, Katharine Munckton, Katherine Borges, Matthew Banghart, Matthew Volgraf, Meike Visel, Michael Hayden Berry, Pablo Gorostiza, Richard Kramer, Scott Franklin Geller